Bronchiectasis pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 28: Line 28:
===Immune Response===
===Immune Response===
*Bronchiectasis may involve several processes
*Bronchiectasis may involve several processes
*If there is inflammation, bronchiectasis can result from inflammation via increased levels of:  
*If there is [[inflammation]], bronchiectasis can result from [[inflammation]] via increased levels of:  
:*Reactive oxygen species (ROS)  
:*[[Reactive oxygen species]] (ROS)  
::*A by product for the metabolism of oxygen
::*A by product for the metabolism of [[oxygen]]
::*Increased levels can cause damage to cell structures
::*Increased levels can cause damage to cell structures
:*Elastase  
:*[[Elastase]]
::*Enzyme of a class of proteases that break down elastin
::*[[Enzyme]] of a class of [[proteases]] that break down [[elastin]]
::*Elastin plus collagen determines the mechanical properties of connective tissue
::*[[Elastin]] plus [[collagen]] determines the mechanical properties of [[connective tissue]]
:*Matrix metalloproteinases (MMPs)  
:*[[Matrix metalloproteinases]] (MMPs)  
::*Responsible for the degradation of most of the extracellular proteins during normal tissue turnover
::*Responsible for the degradation of most of the extracellular proteins during normal tissue turnover
*Inflammation can also lead to epithelial injury and mucus secretion via increased levels of ROS, elastase, ciliotoxin, and mucus secretogogues
*[[Inflammation]] can also lead to epithelial injury and [[mucus]] secretion via increased levels of ROS, [[elastase]]  ciliotoxin and [[mucus]] secretogogues
*Epithelial injury and mucus hypersecretion lead to chronic bronchial infection, reduced mucociliary clearance, and plugging of the airway - which all eventually leads to airway damage and bronchiectasis
*[[Epithelial]] injury and [[mucus]] hypersecretion lead to chronic [[bronchial]] infection, reduced mucociliary clearance, and plugging of the airway - which all eventually leads to airway damage and bronchiectasis





Revision as of 19:28, 29 June 2015

Bronchiectasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bronchiectasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bronchiectasis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bronchiectasis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bronchiectasis pathophysiology

CDC on Bronchiectasis pathophysiology

Bronchiectasis pathophysiology in the news

Blogs on Bronchiectasis pathophysiology

Directions to Hospitals Treating Bronchiectasis

Risk calculators and risk factors for Bronchiectasis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.

Overview

Bronchiectasis involves bronchi that are permanently dilated inflamed, and easily collapsible. This results in airflow obstruction and impaired clearance of secretions Cole's Cycle describes how infections and a defect in the host defense are factors for this disease. An immune response also plays a role in the pathogenesis.

Pathophysiology[1]

  • Dilation of the bronchial walls results in airflow obstruction and impaired clearance of secretions
  • The dilated areas interrupt normal air pressure of the bronchial tubes, causing sputum to pool inside the dilated areas instead of being pushed upward
  • The pooled sputum provides an environment favorable to the growth of infectious pathogens
  • The more infections that the lungs experience, the more damaged the alveoli in the lung become
  • With more damage to the lung tissue, the bronchial tubes become more inelastic and dilated
  • This creates a perpetual, destructive cycle
  • The biopsies indicate that the infiltrate contains neutrophils, T lymphocytes and macrophages
  • The sputum contains elastase, interleukin-8, tumor necrosis factor a (TNF-a), and prostanoids

Cole's Cycle[2]

  • Also known as Cole's "vicious cycle hypothesis"
  • The most widely known model of the development of bronchiectasis
  • Impaired muco-ciliary clearance due to genetic susceptibility causes environmental insult
  • Results in persistence of microbes in the sinobronchial tree
  • The microbial infection causes chronic inflammation
  • This results in tissue damage and impaired mucociliary motility
  • This leads to more infection with a cycle of inflammation causing lung damage
  • Two factors required for the development of this condition are persistent infection and a defect in host defense

Immune Response

  • Bronchiectasis may involve several processes
  • If there is inflammation, bronchiectasis can result from inflammation via increased levels of:
  • A by product for the metabolism of oxygen
  • Increased levels can cause damage to cell structures
  • Responsible for the degradation of most of the extracellular proteins during normal tissue turnover
  • Inflammation can also lead to epithelial injury and mucus secretion via increased levels of ROS, elastase ciliotoxin and mucus secretogogues
  • Epithelial injury and mucus hypersecretion lead to chronic bronchial infection, reduced mucociliary clearance, and plugging of the airway - which all eventually leads to airway damage and bronchiectasis


The diagram below depicts the immune response for bronchiectasis

References

  1. Morrissey BM (2007). "Pathogenesis of bronchiectasis". Clin Chest Med. 28 (2): 289–96. PMID 17467548.
  2. King PT (2009). "The pathophysiology of bronchiectasis". Int J Chron Obstruct Pulmon Dis. 4: 411–9. PMC 2793069. PMID 20037680.


Template:WikiDoc Sources